Uniphar

Lessons from Switzerland

  • Sectors : Pharma and healthcare
  • Companies : Uniphar

Ratings and price correct at time of issue.

  • Uniphar

    Closing Price: 239c

  • RATING 27/08/19

  • PREVIOUS RATING N/A

DAVY VIEW

Swiss-based Galenica has core activities in wholesale and retail distribution, similar to Uniphar’s Supply Chain & Retail (SC&R) division. We see several parallels between the two businesses and a future pathway for Uniphar that could lead to increased margins and profitability. Galenica is valued at 13x 2021 EV/EBITDA, which can be partly explained by its market-leading positions and profit growth. As Uniphar continues to leverage its wholesale platform to execute its retail strategy and drive profits higher, we think investors should start to re-rate Uniphar’s SC&R division over time.

Download full report with analyst certification and important disclosures

Nov 5 2020, 06:45 GMT

Download